ANDREOTTI MOVES TO FARMINDUSTRIA
Lamberto Andreotti, son of the Italian president and director general of drugmaker Farmitalia, has been named vice president of the Italian drug industry association, Farmindustria.
The move is said to be linked to the departure of Roberto Bianchi as managing director of Farmitalia and former vice president of Farmindustria and may indicate it is being speculated - the impending appointment of Mr Andreotti as managing director of Farmitalia.
Meanwhile, at the last routine meeting of the drug industry body attended by Mr Bianchi, the member companies noted that the pharmaceutical industry's workforce is increasing for the first time in some years, having risen by between 1% and 2% in 1991.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze